China Shineway Pharmaceutical Group Limited (HKG:2877)
Hong Kong
· Delayed Price · Currency is HKD 9.85
+0.07 (0.72%)
Apr 29, 2026, 4:08 PM HKT
HKG:2877 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 7,189 | 6,140 | 5,889 | 5,026 | 4,206 | Upgrade
|
| Short-Term Investments | 5.77 | 4.48 | 4.02 | 3.69 | 4.32 | Upgrade
|
| Trading Asset Securities | 376.64 | 350.02 | 20 | 20.23 | - | Upgrade
|
| Cash & Short-Term Investments | 7,571 | 6,495 | 5,913 | 5,050 | 4,210 | Upgrade
|
| Cash Growth | 16.58% | 9.84% | 17.08% | 19.96% | 6.63% | Upgrade
|
| Accounts Receivable | 1,000 | 1,202 | 1,260 | 975.06 | 825.18 | Upgrade
|
| Other Receivables | 24.8 | 66.81 | 63.92 | 67.48 | 40.87 | Upgrade
|
| Receivables | 1,025 | 1,269 | 1,324 | 1,043 | 866.05 | Upgrade
|
| Inventory | 691.3 | 813.19 | 897.71 | 657.66 | 587.96 | Upgrade
|
| Other Current Assets | 16.59 | 22 | 19.94 | 32.01 | 35.06 | Upgrade
|
| Total Current Assets | 9,304 | 8,599 | 8,155 | 6,782 | 5,699 | Upgrade
|
| Property, Plant & Equipment | 1,249 | 1,219 | 1,205 | 1,217 | 1,252 | Upgrade
|
| Goodwill | 165.96 | 165.96 | 165.96 | 165.96 | 165.96 | Upgrade
|
| Other Intangible Assets | 15.72 | 23.32 | 32.79 | 47.35 | 66.43 | Upgrade
|
| Long-Term Deferred Tax Assets | 42.7 | 34.33 | 15.23 | 19.22 | 20.47 | Upgrade
|
| Total Assets | 10,777 | 10,042 | 9,574 | 8,232 | 7,204 | Upgrade
|
| Accounts Payable | 340.03 | 402.96 | 484.79 | 308.75 | 228.62 | Upgrade
|
| Accrued Expenses | 1,190 | 1,199 | 1,121 | 856.76 | 483.21 | Upgrade
|
| Short-Term Debt | 325.05 | 330 | 300 | - | - | Upgrade
|
| Current Portion of Leases | 9.06 | 8.27 | 0.97 | 6.53 | 7.59 | Upgrade
|
| Current Income Taxes Payable | 60.22 | 84.27 | 105.91 | 107.79 | 65.1 | Upgrade
|
| Current Unearned Revenue | 221.86 | 101.75 | 127.4 | 165.22 | 117.05 | Upgrade
|
| Other Current Liabilities | 364.28 | 323.67 | 294.13 | 220.54 | 196.81 | Upgrade
|
| Total Current Liabilities | 2,510 | 2,450 | 2,434 | 1,666 | 1,098 | Upgrade
|
| Long-Term Leases | 0.79 | 8.26 | 0.36 | 0.91 | 7.32 | Upgrade
|
| Long-Term Unearned Revenue | 106.24 | 81.85 | 88.89 | 163.99 | 171.59 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 98.02 | 34.52 | 16.26 | 18.84 | 25.19 | Upgrade
|
| Total Liabilities | 2,715 | 2,575 | 2,539 | 1,849 | 1,302 | Upgrade
|
| Common Stock | 87.66 | 87.66 | 87.66 | 87.66 | 87.66 | Upgrade
|
| Additional Paid-In Capital | 422.14 | 422.14 | 422.14 | 422.14 | 422.14 | Upgrade
|
| Retained Earnings | 8,047 | 7,452 | 7,020 | 6,368 | 5,879 | Upgrade
|
| Comprehensive Income & Other | -494.89 | -494.89 | -494.89 | -494.89 | -487.32 | Upgrade
|
| Shareholders' Equity | 8,062 | 7,467 | 7,035 | 6,383 | 5,901 | Upgrade
|
| Total Liabilities & Equity | 10,777 | 10,042 | 9,574 | 8,232 | 7,204 | Upgrade
|
| Total Debt | 334.9 | 346.53 | 301.33 | 7.44 | 14.91 | Upgrade
|
| Net Cash (Debt) | 7,237 | 6,148 | 5,611 | 5,043 | 4,195 | Upgrade
|
| Net Cash Growth | 17.70% | 9.56% | 11.28% | 20.21% | 17.97% | Upgrade
|
| Net Cash Per Share | 9.58 | 8.14 | 7.43 | 6.68 | 5.56 | Upgrade
|
| Filing Date Shares Outstanding | 755.4 | 755.4 | 755.4 | 755.4 | 755.4 | Upgrade
|
| Total Common Shares Outstanding | 755.4 | 755.4 | 755.4 | 755.4 | 755.4 | Upgrade
|
| Working Capital | 6,794 | 6,149 | 5,721 | 5,117 | 4,601 | Upgrade
|
| Book Value Per Share | 10.67 | 9.88 | 9.31 | 8.45 | 7.81 | Upgrade
|
| Tangible Book Value | 7,880 | 7,278 | 6,836 | 6,169 | 5,669 | Upgrade
|
| Tangible Book Value Per Share | 10.43 | 9.63 | 9.05 | 8.17 | 7.50 | Upgrade
|
| Machinery | 2,741 | 2,798 | 1,489 | 1,438 | 1,392 | Upgrade
|
| Construction In Progress | 335.57 | 195.51 | 117.68 | 193.06 | 130.17 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.